19 articles for S Ninkovic
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.

Pfizer
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Ka and mTOR.

Pfizer
Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyr

Pfizer
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.

Pfizer
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors.

Pfizer
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.

Pfizer
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer.

Pfizer
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.

Pfizer
ACRYLAMIDE COMPOUNDS

NRG Therapeutics
ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP1) INHIBITORS AND USES THEREOF

Insilico Medicine IP
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

Bayer Aktiengesellschaft
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors

Incyte
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors

Bayer Pharma Aktiengesellschaft
Dihydropyrrolopyridine inhibitors of ROR-gamma

Vitae Pharmaceuticals
Conjugate comprising a neurotensin receptor ligand and use thereof

3B Pharmaceuticals
Heteroaryl compounds and uses thereof

Celgene Car
Inhibitors of the renal outer medullary potassium channel

Merck Sharp & Dohme
The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.

University of Defence
Heterocyclic compounds

Shionogi